Accelerate Diagnostics Alpha and Beta Analysis
| AXDXDelisted Stock | USD 0.04 0.02 164.90% |
This module allows you to check different measures of market premium (i.e., alpha and beta) for all equities such as Accelerate Diagnostics. It also helps investors analyze the systematic and unsystematic risks associated with investing in Accelerate Diagnostics over a specified time horizon. Remember, high Accelerate Diagnostics' alpha is almost always a sign of good performance; however, a high beta will depend on investors' risk tolerance level and may signal increased volatility and potential future overvaluation. Key technical indicators related to Accelerate Diagnostics' market risk premium analysis include:
Beta 1.38 | Alpha (3.77) | Risk 0.0 | Sharpe Ratio 0.0 | Expected Return 0.0 |
Alpha is a measure of relative performance on a risk-adjusted basis, while beta measures volatility against the benchmark. The goal is to know if an investor is being compensated for the volatility risk taken. The return on investment might be better than its reference but still not compensate for the assumption of the risk.
Accelerate |
Accelerate Diagnostics Market Premiums
Investors always prefer to have the highest possible return on investment, coupled with the lowest possible volatility. Accelerate Diagnostics market risk premium is the additional return an investor will receive from holding Accelerate Diagnostics long position in a well-diversified portfolio. The market premium is part of the Capital Asset Pricing Model (CAPM), which most analysts and investors use to calculate the acceptable rate of return on investment in Accelerate Diagnostics. At the center of the CAPM is the concept of risk and reward, which is usually communicated by investors using alpha and beta measures. Alpha and beta are two of the key measurements used to evaluate Accelerate Diagnostics' performance over market.| α | -3.77 | β | 1.38 |
Accelerate Diagnostics Fundamentals Vs Peers
Comparing Accelerate Diagnostics' fundamentals to the average values of its peers is one of the most widely used and accepted methods of equity analyses. It helps to analyze Accelerate Diagnostics' direct or indirect competition across all of the common fundamentals between Accelerate Diagnostics and the related equities. This way, we can detect undervalued stocks with similar characteristics as Accelerate Diagnostics or determine the stocks which would be an excellent addition to an existing portfolio. Peer analysis of Accelerate Diagnostics' fundamental indicators could also be used in its relative valuation, which is a method of valuing Accelerate Diagnostics by comparing valuation metrics with those of similar companies.
| Better Than Average | Worse Than Average | Compare Accelerate Diagnostics to competition |
| Fundamentals | Accelerate Diagnostics | Peer Average |
| Return On Asset | -0.74 | -0.14 |
| Operating Margin | (2.82) % | (5.51) % |
| Current Valuation | 50.42 M | 16.62 B |
| Shares Outstanding | 25.29 M | 571.82 M |
| Shares Owned By Insiders | 38.30 % | 10.09 % |
| Shares Owned By Institutions | 17.91 % | 39.21 % |
| Number Of Shares Shorted | 297.38 K | 4.71 M |
Accelerate Diagnostics Opportunities
Accelerate Diagnostics Return and Market Media
The Stock received substential amount of media coverage during this period. Price Growth (%) |
| Timeline |
1 | Accelerate Diagnostics CFO Patience David sells 583 in stock By Investing.com - Investing.com South Africa | 02/28/2025 |
2 | Accelerate Diagnostics Submits WAVE System and Gram-Negative Positive Blood Culture Menu to the FDA for 510 Clearance | 03/21/2025 |
3 | Accelerate Diagnostics Inc reports results for the quarter ended December 31 - Earnings Summary - TradingView | 03/26/2025 |
4 | Accelerate Diagnostics CFO sells shares worth 4,8 - Investing.com | 04/02/2025 |
5 | Insider Selling Accelerate Diagnostics, Inc. CEO Sells 25,343 Shares of Stock | 04/08/2025 |
6 | Accelerate Diagnostics CEO Retention Bonus Agreement - TipRanks | 04/25/2025 |
7 | Accelerate Diagnostics Files for Chapter 11 Protection and Agrees to Terms to Sell ... | 05/08/2025 |
8 | Accelerate Diagnostics, Inc. dropped from SP TMI Index - marketscreener.com | 05/12/2025 |
About Accelerate Diagnostics Beta and Alpha
For many years both, Alpha and Beta indicators are used by professional money managers as critical performance measurement tools across virtually all financial instruments including Accelerate or other delisted stocks. Alpha measures the amount that position in Accelerate Diagnostics has returned in comparison to a selected market index or another relevant benchmark. In other words, Alpha is the excess return on an investment relative to the performance of your selected benchmark. Beta, on the other hand, measures the relative risk of your investment.
Accelerate Diagnostics Upcoming Company Events
As portrayed in its financial statements, the presentation of Accelerate Diagnostics' financial position is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, Accelerate Diagnostics' leadership is honest, while the outside auditors are strict and uncompromising. Whatever the case, investors should always follow all of Accelerate Diagnostics' public filing events to personally review all filings and be reasonable and skeptical to interpret all of the financial statements of Accelerate Diagnostics. Please utilize our Beneish M Score to check the likelihood of Accelerate Diagnostics' management manipulating its earnings.
| 3rd of April 2024 Upcoming Quarterly Report | View | |
| 9th of May 2024 Next Financial Report | View | |
| 31st of December 2023 Next Fiscal Quarter End | View | |
| 3rd of April 2024 Next Fiscal Year End | View | |
| 30th of September 2023 Last Quarter Report | View | |
| 31st of December 2022 Last Financial Announcement | View |
Build Portfolio with Accelerate Diagnostics
Your optimized portfolios are the building block of your wealth. We provide an intuitive interface to determine which securities in a portfolio should be removed or rebalanced to achieve better diversification, find the right mix of securities that minimizes portfolio risk for a given return, or maximize portfolio expected return for a given risk level.Build Diversified Portfolios
Align your risk with return expectations
Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in small area income & poverty estimates. You can also try the Funds Screener module to find actively-traded funds from around the world traded on over 30 global exchanges.
Other Consideration for investing in Accelerate Stock
If you are still planning to invest in Accelerate Diagnostics check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Accelerate Diagnostics' history and understand the potential risks before investing.
| Balance Of Power Check stock momentum by analyzing Balance Of Power indicator and other technical ratios | |
| Global Markets Map Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes | |
| Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments | |
| Top Crypto Exchanges Search and analyze digital assets across top global cryptocurrency exchanges | |
| Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. | |
| Idea Analyzer Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas | |
| Stock Screener Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook. | |
| Price Transformation Use Price Transformation models to analyze the depth of different equity instruments across global markets | |
| Financial Widgets Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets |